On Wednesday, Shares of Transocean LTD (NYSE:RIG), added 5.88% and closed at $10.08 in the last trading session. The last trading range of the stock ranges between $9.62 and $10.15. Transocean Ltd. (RIG) declared recently that Reliance Industries Ltd. (Reliance) has elected to exercise its contractual option to terminate the contract for the ultra-deepwater drillship Discoverer India, effective December 2016, before its expiration in January 2021. In accordance with the contract, Transocean will be compensated by Reliance and its partners for the early termination through a lump-sum payment of about $160 million.
Johnson & Johnson (NYSE:JNJ), jumped 0.30% and closed at $119.18 in the last trading session. The last trading range of the stock ranges between $118.60 and $119.44. The company’s Market capitalization is $326.09 Billion with the total Outstanding Shares of 2.74 Billion. Johnson & Johnson, together with its auxiliaries, researches and develops, manufactures, and sells various products in the health care field worldwide. It operates through three segments: Consumer, Pharmaceutical, and Medical Devices. The Consumer segment offers baby care products under the JOHNSONS brand name; oral care products under the LISTERINE brand name; skin care products under the AVEENO, CLEAN & CLEAR, DABAO, JOHNSONS Adult, LE PETITE MARSEILLAIS, LUBRIDERM, NEUTROGENA, and RoC brand names; womens health products, such as sanitary pads under the STAYFREE and CAREFREE, and o.b. tampon brand names; wound care products, counting adhesive bandages under the BAND-AID brand name and first aid products under the NEOSPORIN brand name. This segment also provides over-the-counter medicines, counting acetaminophen products under the TYLENOL brand name; cold, flu, and allergy products under the SUDAFED brand name; allergy products under the BENADRYL and ZYRTEC brand names; ibuprofen products under the MOTRIN IB brand name; and heartburn products under the PEPCID brand name. The Pharmaceutical segment provides various products in the areas of immunology, infectious diseases and vaccines, neuroscience, oncology, and cardiovascular and metabolic diseases. The Medical Devices segment offers orthopaedic products; general surgery, biosurgical, endomechanical, and energy products; electrophysiology products to treat cardiovascular disease; sterilization and disinfection products to reduce surgical infection; blood glucose monitoring and insulin delivery products; and disposable contact lenses.
Vodafone Group Plc (ADR) (NASDAQ:VOD), LOST -0.68% and closed at $29.10 in the last trading session. The last trading range of the stock ranges between $28.99 and $29.21. During the 52-week trading session the minimum price at which share price traded, registered at $27.92 and reached to max level of $34.70. Vodafone Group Plc operates as a telecommunications company worldwide. The company offers voice, messaging, and data services across mobile and fixed networks; broadband and TV services; cloud and hosting, in addition to Internet protocol-virtual private network services; roaming services; and unified communications services. It also provides M-Pesa, a mobile money transfer and payment service; and Vodafone One, an ultra-high-speed fixed broadband service with Ono Fibre, home landline, 4G mobile telephony, and Vodafone TV. In addition, Vodafone Group Plc offers Internet of Things (IoT), which is communication between devices via mobile technologies; international voice transit and roaming; carrier services, such as fixed and mobile connectivity and other services; and smartphones and tablets.